Episode
HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the 2025 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer®️
- Podcast
- Gynecologic Oncology Update
- Published
- Apr 3, 2025
- Duration seconds
- 5361
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/gynecologic-oncology-update-612940/episodes/her2-positive-gynecologic-cancers-proceedings-from-a-session-held-during-the-2025-society-of-gynecologic-oncology-annual-meeting-on-women-s-cancer/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/gynecologic-oncology-update-612940/her2-positive-gynecologic-cancers-proceedings-from-a-session-held-during-the-2025-society-of-gynecologic-oncology-annual-meeting-on-women-s-cancer.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Drs Kathleen N Moore and Alessandro D Santin and moderator Dr David M O’Malley summarize and share their perspectives on data guiding the management of HER2-positive gynecologic cancers that were presented at the Society of Gynecologic Oncology 2025 annual meeting. CME information and select publications here .